Honokiol inhibits human osteosarcoma MG63 cell migration by upregulating FTO and Smad6 to promote autophagy
Background: Osteosarcoma (OS) is a common primary malignant tumor of bone, most commonly seen in children and adolescents, which has a low survival rate and is a serious threat to patients' lives. Honokiol (HKL) is the main active components of Magnolia officinalis, which have significant anti-...
Saved in:
| Main Authors: | Jian Wu, Wenqiang Xu, Jingchi Li, Cheng Luo, Bo Chen, Luo Lin, Tianyu Huang, Tao Luo, Lin Yang, Jiexiang Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Molecular and Cellular Probes |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0890850824000409 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
by: Qi Song, et al.
Published: (2024-12-01) -
Enhanced penetration and biofilm eradication by sophorolipid micelles encapsulating Honokiol: a comprehensive solution for biofilm-associated lung infections
by: Shiyu Lin, et al.
Published: (2025-02-01) -
Effects of honokiol combined with resveratrol on bacteria responsible for oral malodor and their biofilm
by: Shiqian Zheng, et al.
Published: (2024-12-01) -
Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01) -
Repurposing old natural compounds to target new pathogens: honokiol and magnolol against Candida auris
by: Mihai Mares, et al.
Published: (2024-12-01)